Home/Stocks/Energy

Drax Group PLC

DRX.L·Energy·Market Cap £2.6b
Rank #150 of 280
Quantitative Model · 280 Stocks Analysed
£7.86
-6.15% YTD
52W: £6.96 - £9.38

Factor Analysis Summary

Editorial assessment generated from Drax Group PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Drax Group PLC (DRX.L) currently holds an overall rank of #150 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively; market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation; and valuation (P/E 143.7, dividend yield 3.8%), where it demonstrates reasonable valuation with several price-based metrics ranking favourably.

Areas requiring attention include profitability (ROE 3.9%, net margin 0.3%), where compressed margins and weak returns on equity weigh on the earnings profile, as well as liquidity, where thin trading volumes could increase transaction costs and slippage.

Within the Energy sector, Drax Group PLC sits at composite rank #150, trailing the Energy peer average (rank 118). Among 7 Energy names in our coverage, it ranks above 2 peers and below 4.

The composite profile is weighed down by 3 below-average factor scores, with profitability (rank 270/280) representing the most significant drag on its #150 overall standing.

Strongest Factors

  • Asset Efficiency — Rank 26/280 (top quartile)
  • Market Trading — Rank 59/280 (top quartile)
  • Valuation — Rank 105/280 (above average)

Weakest Factors

  • Profitability — Rank 270/280 (below average)
  • Liquidity — Rank 225/280 (below average)

Score Analysis

Drax Group PLC is ranked #150 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

147/280
Average Score
Liquidity
Weak225/280
Valuation
Good105/280
Profitability
Weak270/280
Solvency
Fair155/280
Asset Efficiency
Excellent26/280
Mkt Trading
Excellent59/280
Technical
Weak189/280

1. Liquidity

Score: 225/280

How liquid is DRX and can it meet its short-term obligations?

2/6
liquidity criteria met
✓
Quick Ratio0.91x
Range: 0.8 - 1.3Rank 80/280
✓
Current Ratio1.07x
Range: 1.0 - 1.5Rank 156/280
✗
TTM Operating Cash Flow0.31x
Range: 1.0 - 2.0Rank 162/280
–
Liquidity Coverage RatioN/A
Range: N/A
✗
Intangible Asset Ratio0.01x
Range: 3 - 12Rank 146/280
✗
Cash-to-Debt Ratio0.09x
Range: 0.2 - 0.7Rank 203/280

Key Liquidity Metrics

Quick Ratio
0.91x
Sector: 0.8 - 1.3
Current Ratio
1.07x
Sector: 1.0 - 1.5

Overall Liquidity Rank

Rank within universe#225/280
Best (1)Worst (280)

2. Valuation

Score: 105/280

Is DRX undervalued compared to its peers and fair value metrics?

5/7
valuation criteria met
✓
FY27e P/E14.3x
Range: 8x - 18xRank 152/280
✓
FY26e P/E9.7x
Range: 8x - 18xRank 41/280
✓
FY27e Net Div Yld (%)4.49%
Range: 3.0 - 7.0Rank 79/280
✗
Div Payout Ratio507.80%
Range: 35 - 65Rank 25/280
✗
Current EV/EBITDA3.9x
Range: 5.0x - 9.0xRank 34/280
✓
Current P/TBV2.24x
Range: 1.0x - 3.0xRank 133/280
✓
Current P/B1.66x
Range: 1.0x - 3.0xRank 145/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
143.7x
FY26e P/E
Forward estimate
9.7x
FY27e P/E
Forward estimate
14.3x
Current P/B
Price-to-Book
1.66x
Current P/TBV
Tangible Book Value
2.24x
Current EV/EBITDA
Enterprise Value
3.9x
FY26e EV/EBITDA
Forward estimate
5.6x
FY27e EV/EBITDA
Forward estimate
5.6x

Dividend

DRX pays a dividend yield of 3.82%.

Current Yield
3.82%
FY27e Net Div Yield
4.49%
FY26e Gross DPS
0.321
FY27e Gross DPS
0.353

Dividend Per Share Forecast

3. Profitability

Score: 270/280

How profitable is DRX relative to its peers?

1/7
profitability criteria met
✗
TTM Profit Margin0.3%
Range: 8 - 16Rank 248/280
✗
T12 FCF Margin0.8%
Range: 10 - 25Rank 83/280
✓
FY27e RoE10.3%
Range: 10 - 18Rank 151/280
✗
FY26 EPS Growth-41.1%
Range: 15 - 30Rank 221/280
✗
FY27e EPS Growth-60.0%
Range: 0 - 12Rank 223/280
–
NIMN/A
Range: N/A
–
Expense RatioN/A
Range: 70 - 80
TTM Profit Margin
0.3%
Current RoCE
3.9%
FY27e RoE
10.3%
T12 FCF Margin
0.8%

EPS Growth

4. Solvency

Score: 155/280

How strong is DRX's balance sheet and financial position?

2/6
solvency criteria met
✓
Debt/Eqt0.63x
Range: 0.5x - 1.0xRank 162/280
–
Interest Coverage RatioRank 129
Range: 5x - 12xRank 129/280
✓
Net Leverage Ratio2.49x
Range: 1.0x - 2.5xRank 142/280
–
Altman Z-Score (Manufacturing)3.47
Range: <1.10 - >2.60Rank 158/280
–
Z-Score (Non Manufacturing)Rank 147
Range: <1.10 - >2.60Rank 147/280
–
CapAdeq Ratio Tier1N/A
Range: N/A

Key Solvency Metrics

Debt/Eqt
0.63x
Net Leverage Ratio
2.49x
Interest Coverage
Rank 129
T12 FCF Margin
0.8%

Altman Z-Score

3.47
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 26/280

How efficiently does DRX deploy its assets and intellectual capital?

1/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: N/A
✓
TTM Asset Turnover Ratio1.03x
Range: 0.5x - 1.2xRank 51/280
✗
TTM CAPEX/Sales4.9%
Range: 6 - 10Rank 89/280
✗
Working Capital Turnover74.09x
Range: 4x - 10xRank 6/280
–
R&D/Sales FY27eN/A
Range: 0.2 - 0.5

Overall Asset Efficiency Rank

Rank within sector peers#26/280
Best (1)Worst (280)

6. Market Trading

Score: 59/280

How liquid and actively traded is DRX?

1/2
market trading criteria met
✗
Intraday Sentiment (%)83.0%
Range: 40 - 70Rank 39/280
–
10D-Avg v/s 3M-Avg Vol90%
Range: N/ARank 50/280
✓
Avg Directional Index 30D23.1
Range: 15 - 60Rank 96/280
–
Parabolic SAR811.95
Range: N/ARank 109/280
–
Stock Rating RankRank 50
Range: N/ARank 50/280
Market Cap
£2,644,132,303
Enterprise Value
£3,663,231,685

Trading Volume

7. Technical

Score: 189/280

What do the technical indicators say about DRX?

0/5
technical criteria met
–
CMP v/s 52-WH-16.2%
£9.38£6.96
-16.2%CMP: £7.86
Range: N/ARank 181/280
–
CMP v/s 52-WL12.9%
£9.38£6.96
+12.9%CMP: £7.86
Range: N/ARank 67/280
–
RSI 14D34.0
034.0 - Bearish100
Range: N/ARank 50/280
–
MA50 - MA200Bearish
£7.76-0.49£8.24
Range: N/ARank 247/280
–
MACD Rank-5.99
Death Cross
MACD: -5.99
Range: N/A

RSI (14 Day)

34.0
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£7.76
200 SMA£8.24
SignalDeath Cross (Bearish)
MACD-5.99

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does DRX compare to other Energy stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
DRX#15022510527015559189
SHEL.L#116582691384331
HBR.L#45593107200241249
ENOG.L#12121520142265204201
ITH.L#1322627218217817784
CWR.L#17916209276136242273
BP.L#22718167120225142151
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Drax Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.